Stephen Faraone, PhD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Otsuka
    Topic:
    Research Grants/CME Grant Support/Consulting
    Date added:
    01/25/2022
    Date updated:
    01/25/2022
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Sunovion
    Topic:
    Research Grants/CME Grant Support
    Date added:
    01/25/2022
    Date updated:
    01/25/2022
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Supernus
    Topic:
    Research Grants/Advisory Board
    Date added:
    01/25/2022
    Date updated:
    01/25/2022
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Shire/Takeda
    Topic:
    CME Grant Support
    Date added:
    01/25/2022
    Date updated:
    01/25/2022
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Akili Interactive Labs, Aardvark, Aveksham, Enzymotec, Ironshore, Noven, Rhodes, Tris, and Vallon
    Topic:
    Consultation
    Date added:
    01/25/2022
    Date updated:
    01/25/2022
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Arbor, Ondosis, KemPharm/Corium
    Topic:
    Consultation/Advisory Board
    Date added:
    01/25/2022
    Date updated:
    01/25/2022
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Genomind
    Topic:
    Consulting/Advisory Board/Stock:
    Date added:
    01/25/2022
    Date updated:
    01/25/2022
  • Attribution:
    Self
    Type of financial relationship:
    Financial Support
    Ineligible company:
    Elsevier, Guilford Press, Oxford University Press
    Topic:
    Royalties
    Date added:
    01/25/2022
    Date updated:
    01/25/2022
Return to Advances in the Treatment of Psychiatric Disorders: Innovations and Future Directions